Do Biopsies Spread Cancer? Addressing Needle Track Fears

A needle biopsy disturbs a tumor, so cancer cells travel back along the needle path and spread through the body. Safer, the reasoning goes, to leave it alone.

The idea is intuitive. Poke something and pieces come loose. People also notice that cancer sometimes looks worse after a biopsy than it did before, and the timing feels like cause and effect even when the stage was already there and the biopsy simply revealed it. Rare case reports do exist, and they travel far online because they are frightening. Reasoning this way does not make you gullible. It makes you someone working from the information in front of you.

Seeding — cancer cells left behind along a needle track — is a real, documented event. It is also uncommon, and it is less common than it used to be.

• The National Cancer Institute states that the chance surgery or a biopsy causes cancer to spread to other parts of the body is extremely low.
• The liver is the most-studied site, because seeding was reported there most often. A 2024 meta-analysis in BJS Open pooled 23 studies covering 8,857 patients and found seeding in about 1% of people who had a biopsy alone. A 2008 meta-analysis had put the figure at 2.7%. The authors attribute much of the drop to coaxial technique, where the needle passes through a protective outer sheath instead of through tissue directly.
• Prostate biopsy is among the most commonly performed procedures in medicine. A 2015 review in BJU International searched the world literature and found 42 reported cases of needle-tract seeding in total across 26 publications, concluding the incidence is well under 1%.
• In breast cancer, displaced cells are actually found fairly often — a systematic review found malignant cells in the biopsy path in about 22% of surgical specimens. Those cells mostly do not survive. The same review found no increase in local recurrence, and the one study that looked at overall survival found no difference.

Radiologists and surgeons also take specific steps: coaxial needles, an approach that avoids crossing body cavities, planning the needle path so it lies within tissue that would be removed at later surgery, and using separate instruments for different areas during an operation.

It does not mean seeding never happens. It does. It does not mean every biopsy is the same — some tumor types and locations carry a slightly higher risk, and that is part of what your radiologist weighs when planning. And it does not mean you are required to feel calm about it. Being frightened of a needle going into a tumor is not irrational.

This is the part that matters most. A biopsy is how a cancer is identified — the type, the grade, the receptors and mutations that decide which treatment will work at all. Without that tissue, treatment is guesswork, or it does not start. Weeks or months spent avoiding a biopsy are weeks or months a cancer can grow and spread on its own, which is a far more common outcome than seeding. The precaution can end up costing more than the thing it was meant to prevent.

Seeding is real, uncommon, and getting less common as technique improves. Delayed diagnosis is none of those things. If this fear is what is holding you back, say it out loud to your radiologist or care team — ask what technique they will use, whether a coaxial needle is planned, and whether the needle path can be taken out later. Those questions have answers, and asking them usually helps more than deciding alone.

• NCI — How Cancer Is Diagnosed
• Maducolil et al., BJS Open 2024 — Risk of tumour seeding after liver biopsy: meta-analysis (23 studies, 8,857 patients)
• Volanis et al., BJU International 2015 — Incidence of needle-tract seeding after prostate biopsy
• Liebens et al., Maturitas 2009 — Breast cancer seeding associated with core needle biopsies: a systematic review
• Holmes, Cancers 2024 — Reducing the risk of needle tract seeding during needle biopsy